These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 30499494)
21. [Clinical efficacy of cytoflavin in the combined treatment of patients during acute phase of ischemic stroke]. Shestakov VV; Kosenkova NV; Kichigina EV; Larikova TN; Starikova NL Klin Med (Mosk); 2011; 89(1):38-40. PubMed ID: 21516764 [TBL] [Abstract][Full Text] [Related]
22. [The efficiency of cytoflavin and ozonotherapy in complex treatment of the myasthenia]. Drozd OA; Efremov VV; Dudarev IV Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(1):46-9. PubMed ID: 23528494 [No Abstract] [Full Text] [Related]
23. [Influence of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndrome]. Muratov FK; Shermukhamedova FK; Batocyrenov BV; Haritonova TV Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(12):44-47. PubMed ID: 28139625 [TBL] [Abstract][Full Text] [Related]
24. [Efficacy of cytoflavin in the treatment of hypoxic-ischemic lesions of the nervous system in 1-month old children with transient neonatal hypothyroidism]. Strukov VI; Maksimova MN; Kuptsova TA; Lysev SF; Shcherbakova YG Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(10):17-20. PubMed ID: 26525615 [TBL] [Abstract][Full Text] [Related]
25. [SUBSTANTIATION OF INDICATIONS FOR BIOFEEDBACK THERAPY AND CYTOFLAVIN APPLICATION IN TREATMENT OF OSTEOCHONDROSIS NEUROLOGICAL COMPLICATIONS IN ELDERLY PATIENTS]. Parfenov Y; Vasilevskaya M; Parfenov S; Sapozhnikov K; Kovalenko A; Zaplutanov V Georgian Med News; 2018 Oct; (283):89-96. PubMed ID: 30516501 [TBL] [Abstract][Full Text] [Related]
26. [Efficacy of cytoflavin in the treatment of chronic cerebral ischemia]. Suslina ZA; Klocheva EG; Piradov MA; Rumiantseva SA; Romantsov MG; Kovalenko AL Klin Med (Mosk); 2010; 88(3):50-3. PubMed ID: 20608066 [TBL] [Abstract][Full Text] [Related]
27. [The use of cytoflavin in the complex treatment of patients with tick-borne encephalitis]. Selezneva AG; Petrova AG Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(7):68-9. PubMed ID: 23011438 [No Abstract] [Full Text] [Related]
28. [Assessment of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndrome]. Asadullaev MM; Saidvaliev FS; Shermukhamedova FK; Rizvonov ZhK; Vakhabova NM Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(10):24-7. PubMed ID: 23250593 [TBL] [Abstract][Full Text] [Related]
29. [Cytoflavin in the complex treatment of neuroinfections in children]. Skripchenko NV; Egorova ES Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(9):28-31. PubMed ID: 22027666 [TBL] [Abstract][Full Text] [Related]
30. [Improvement of speech discrimination with cytoflavin in patients with chronic sensorineural deafness]. Zhuravskiĭ SG Vestn Otorinolaringol; 2010; (4):82-6. PubMed ID: 21105353 [No Abstract] [Full Text] [Related]
31. [The use of cytoflavin in the acute period of hemorrhagic stroke]. Sazonov IE; Klementenko TD; Kudinov AA; Avramenko MA; Yarmonov SN Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(2):23-26. PubMed ID: 29560936 [TBL] [Abstract][Full Text] [Related]
32. [Clinical efficacy of neurometabolic therapy of dissomical disorders in asthenic syndrome]. Esipov AV; Ivolgin AF; Khritinin DF; Katenko SV; Kazakov SP; Karakozov AG; Kalyagin IE; Levchenko OB; Molodova AI Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9):46-51. PubMed ID: 31626218 [TBL] [Abstract][Full Text] [Related]
33. [Cytoflavin in polychemotherapy of breast cancer]. Kashuro VA; Glushkov SI; Zheregelia SN Antibiot Khimioter; 2010; 55(7-8):30-3. PubMed ID: 21140562 [TBL] [Abstract][Full Text] [Related]
34. [Dynamics of the symptoms of chronic ischemia during the treatment with cytoflavin]. Madzhidova EN; Usmanova DD; Baĭtursunova ZhM Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9):57-62. PubMed ID: 23235414 [TBL] [Abstract][Full Text] [Related]
35. [Cytoflavin in the treatment of preschool and early school age children with the consequences of perinatal hypoxic brain damages]. Lavrick SY; Shprakh VV; Domitrak SV; Borisov AS Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10):34-37. PubMed ID: 27845313 [TBL] [Abstract][Full Text] [Related]
36. [The effectiveness of the combined use of energomonitor antioxidant and cognitive psychotherapy in the treatment of generalized periodontitis in elderly patients]. Ashour АZ; Belov VG; Parfyonov UA; Parfyonov SA; Ershov EV; Tuchin IA; Kovalenko AL; Talikova EV Stomatologiia (Mosk); 2016; 95(2):14-17. PubMed ID: 27239991 [TBL] [Abstract][Full Text] [Related]
37. [Efficacy of the complex drug cytoflavin in the treatment of consequences of mild brain injury]. Skoromets AA; Pugacheva EL Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3):31-6. PubMed ID: 20517223 [TBL] [Abstract][Full Text] [Related]
38. [Pathogenetic aspects of the use of cytoflavine in the treatment of сhronic post-traumatic headache]. Iskra DA Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11):41-44. PubMed ID: 28091500 [TBL] [Abstract][Full Text] [Related]
39. [The use of neurometabolic treatment in the complex rehabilitation in poststroke patients]. Kovalchuck VV; Khafizova TL; Galkin AS Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(11):61-6. PubMed ID: 25591638 [TBL] [Abstract][Full Text] [Related]
40. [Investigation of the effects of cytoflavin on symptoms of depression and autonomic dysfunction in patients with organic depressive disorder]. Gudkova AN; Osinovskaia NA; Polunina AG; Gekht AB Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(12):50-5. PubMed ID: 24430035 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]